The Global Cancer Immunotherapy Market achieved a valuation of $121.2 Billion in 2023 and is anticipated to exceed $245.37 ...

Imugene's trial programs could result in the first 'off the shelf' Car-T therapy that uses healthy donors' cells.

The BC Cancer Foundation has launched a $6.8 million fundraising campaign to expand provincial immunotherapy research program ...

Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

The woman, who had neuroblastoma as a child, had two healthy pregnancies since undergoing the trial, which uses modified ...

MaxCyte's technology will support TG Therapeutics' efforts to develop a CD19 CAR-T cell therapy program for autoimmune diseases.

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its Chairman and CEO, Dr. Amit Kumar, ...

The Penn physician-researcher has received more funding to advance his 'Trojan horse' for attacking gastroesophageal cancer.

The BC Cancer Foundation is looking to raise $6.8 million to expand its provincial immunotherapy research program, a ...

The American Society for Transplantation and Cellular Therapy® (ASTCT®) is pleased to announce David L. Porter, MD, as the ...

Pancreatic cancer, one of the most aggressive and lethal types of cancer, continues to present significant challenges in both ...